Immunic (IMUX) Stock Statistics & Valuation Metrics

Immunic has a market cap or net worth of $93.83M. The enterprise value is $79.74M.

Immunic has 95,817,535 shares outstanding. The number of shares has decreased by -2.65% in one year.

Immunic’s return on equity (ROE) is -5.45 and return on invested capital (ROIC) is -504.56%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Immunic had revenue of 0.00 and earned -100.51M in profits. Earnings per share was -1.00.

In the last 12 months, operating cash flow was -51.05M and capital expenditures -2.34M, giving a free cash flow of -53.39M billion.

Immunic pays an annual dividend of ―, resulting in a dividend yield of ―

Immunic upcoming earnings date is Aug 7, 2025, Before Open (Confirmed).

Immunic as a current ratio of 1.77, with Debt / Equity ratio of -3.97%

In the past 12 months, Immunic has paid 0.00 in taxes.

Immunic EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -0.77.

Immunic has $14.30M in cash and marketable securities with $975.00K in debt, giving a net cash position of -$13.33M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Immunic is $6.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy